This phase I, three-period, open-label, Single-Sequence study of a drug–drug interaction of verapamil with omadacycline on the pharmacokinetic profile of omadacycline in healthy adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Nov 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Omadacycline (Primary) ; Verapamil (Primary)
Indications Anthrax; Community-acquired pneumonia; Cystitis; Pyelonephritis; Skin and soft tissue infections; Urinary tract infections
Focus Adverse reactions; Pharmacokinetics

23 Nov 2020 New trial record
12 Nov 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com